Padgham C, Hinton J M, Birch N J
Biomedical Research Laboratory, School of Health Sciences, University of Wolverhampton, England.
J Am Coll Nutr. 1994 Oct;13(5):473-8. doi: 10.1080/07315724.1994.10718437.
The study investigated lithium-sodium countertransport in erythrocytes of normal female volunteers during different phases of the menstrual cycle or during administration of oral contraceptives.
Ten normally menstruating, and eight oral contraceptive using, normal female subjects were studied over at least one cycle. Erythrocyte lithium-sodium countertransport was determined using. standard, previously validated methods at different phases of the menstrual cycle. Hematological, electrolyte, blood pressure and other transport measures were also made and these were related to the self-reported incidence of premenstrual symptomatology.
A correlation, (p < 0.02), was found between lithium-sodium countertransport rate and the premenstrual symptom severity score but only in the premenstrual phase. There was no correlation between any of the electrolyte, blood pressure or hematological data and lithium-sodium countertransport rate nor between it and other ion transport measures. Pre-menstrual symptomatology was conspicuously absent from those subjects taking oral contraceptives. Cyclical fluctuations in normally menstruating women, and differences between them and oral contraceptive users, were seen in lithium-sodium countertransport rate although the groups were too small to show statistical significance.
Care was taken to exclude influences due to circadian, dietary and diurnal variations and the present results show somewhat less within-individual variability in erythrocyte lithium-sodium countertransport during the menstrual cycle than do other reports in the literature. Some interesting features were observed which justify a much larger scale study than the present pilot experiment which should involve a larger number of subjects studied over more than one cycle and in particular a more detailed study of the ovulatory phase.
本研究调查正常女性志愿者在月经周期不同阶段或口服避孕药期间红细胞中的锂-钠逆向转运情况。
对10名正常月经周期的女性和8名服用口服避孕药的正常女性受试者进行了至少一个周期的研究。使用标准的、先前已验证的方法在月经周期的不同阶段测定红细胞锂-钠逆向转运。还进行了血液学、电解质、血压和其他转运指标的测量,并将这些指标与自我报告的经前症状发生率相关联。
仅在经前阶段发现锂-钠逆向转运速率与经前症状严重程度评分之间存在相关性(p < 0.02)。电解质、血压或血液学数据中的任何一项与锂-钠逆向转运速率之间均无相关性,它与其他离子转运指标之间也无相关性。服用口服避孕药的受试者明显没有经前症状。正常月经周期女性的锂-钠逆向转运速率存在周期性波动,且她们与口服避孕药使用者之间存在差异,尽管样本量太小,无法显示统计学意义。
已注意排除昼夜节律、饮食和日间变化的影响,目前的结果表明,与文献中的其他报告相比,月经周期中红细胞锂-钠逆向转运的个体内变异性略小。观察到了一些有趣的特征,这表明需要进行比当前试点实验规模大得多的研究,该研究应涉及更多受试者,研究周期超过一个周期,特别是对排卵阶段进行更详细的研究。